Der blev randomiseret 813 patienter til behandling med IFL + placebo (arm 1) eller IFL + Avastin (5 mg/ kg hver 2. uge, arm 2).
Eight hundred and thirteen patients were randomised to receive IFL + placebo (Arm 1) or IFL + Avastin (5 mg/ kg every 2 weeks, Arm 2).